102 Grants (Page 2 of 5)
2017
Does GPR119 mediate the beneficial metabolic effects of THC?
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R21DA044004-01), $196,406USD, 04/01/2017 -- 03/31/2019
 
Exploiting CB2 Functional Selectivity for Therapeutic Benefit
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5P01DA009158-18-5294), $234,500USD, 2017
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA041229-02), $315,900USD, 04/15/2016 -- 01/31/2021
 
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system
Mackie, Kenneth P and MANZONI, OLIVIER J
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA043982-01A1), $311,445USD, 08/01/2017 -- 05/31/2022
2016
Adolescent THC, microglial activation, neuroinflammation, and their long-term consequences
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R21DA039463-02), $231,660USD, 04/01/2015 -- 03/31/2017
 
Cannabinoid Modulation of Cell Function
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 4K05DA021696-09), $139,326USD, 10/18/2005 -- 03/31/2018
 
Exploiting CB2 Functional Selectivity for Therapeutic Benefit
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5P01DA009158-17-5294), $232,154USD, 2016
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA041229-01A1), $351,000USD, 04/15/2016 -- 01/31/2021
2015
Adolescent THC, microglial activation, neuroinflammation, and their long-term consequences
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R21DA039463-01), $195,000USD, 04/01/2015 -- 03/31/2017
 
Cannabinoid Modulation of Cell Function
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5K05DA021696-08), $139,326USD, 10/18/2005 -- 03/31/2018
 
Exploiting CB2 Functional Selectivity for Therapeutic Benefit
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5P01DA009158-16-5294), $230,406USD, 2015
2014
Cannabinoid Modulation of Cell Function
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5K05DA021696-07), $139,326USD, 10/18/2005 -- 03/31/2018
 
Exploiting CB2 Functional Selectivity for Therapeutic Benefit
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 2P01DA009158-15A1-5294), $230,502USD, 2014
 
MRI: Acquisition of a High-Density Microelectrode Array for Recording and Stimulating Hundreds of Neurons
Beggs, John⋅Mackie, Ken and Jin, Xiaoming
National Science Foundation (NSF), Directorate for Biological Sciences, Division of Biological Infrastructure (ID: 1429500), $91,555USD, 12/01/2014 -- 11/30/2017
 
Neuronal cannabinoids
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA011322-15), $298,760USD, 04/01/1998 -- 06/30/2015
 
Optimizing analgesia by exploiting CB2 agonist functional selectivity
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R21DA035068-02), $234,000USD, 03/15/2013 -- 02/29/2016
2013
Cannabinoid Modulation of Cell Function
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 2K05DA021696-06), $139,326USD, 10/18/2005 -- 03/31/2018
 
Neuronal cannabinoids
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA011322-14), $286,810USD, 04/01/1998 -- 06/30/2015
 
Optimizing analgesia by exploiting CB2 agonist functional selectivity
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R21DA035068-01A1), $195,000USD, 03/15/2013 -- 02/28/2015
2012
Neuronal cannabinoids
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA011322-13), $298,760USD, 04/01/1998 -- 06/30/2015
2011
Cannabinoid
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R13DA023325-05), $15,000USD, 06/01/2007 -- 05/31/2012
 
Cannabinoid Modulation of Cell Function
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5K05DA021696-05), $129,597USD, 06/05/2007 -- 05/31/2012
 
Do organophosphates impair neurodevelopment through inhibition of endocannabinoid
Lu, Hui Chen and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R21DA029381-02), $186,423USD, 04/01/2010 -- 03/31/2013
 
Molecular Requirements of Cannabinoid Receptor Activity
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5P01DA009158-14), $170,640USD, 2011
 
Neuronal cannabinoids
Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA011322-12), $298,760USD, 04/01/1998 -- 06/30/2015